Plasbumin Solution
Product Images NDC 13533-691

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasbumin (NDC 13533-691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel

Packaging label for Plasbumin-20, containing Albumin (Human) 20% USP solution for intravenous infusion. The vial strength is 10 g/50 mL. The label includes storage instructions, cautions, and product contents. It is labeled for use by Grifols USA, LLC and shows the NDC 13533-691-20. The label also displays a barcode and specifies single-dose vial usage.*

FDA Label Image

Viallabel

Plasbumin 20% solution, 10 g/50 mL single-dose vial label. The product contains Albumin (Human) USP and is for intravenous use. The label displays the NDC 13533-691-21, with Grifols Therapeutics LLC as labeler. The vial strength and volume are prominently shown, with usage instructions and safety warnings included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.